A randomized double-blinded clinical trial to explore the clinical outcome of self-administered vaginal isonicotinic acid hydrazide (INH) administration 12 hours before hysterosalpingography in primarily infertile patients
shady, N., Taha, A., Ahmed, H., Sallam, H. (2023). A randomized double-blinded clinical trial to explore the clinical outcome of self-administered vaginal isonicotinic acid hydrazide (INH) administration 12 hours before hysterosalpingography in primarily infertile patients. EKB Journal Management System, 27(2), 54-64. doi: 10.21608/egyfs.2023.297300
nahla w shady; Ahmed A. Taha; Hala Maher Ahmed; Hany F. Sallam. "A randomized double-blinded clinical trial to explore the clinical outcome of self-administered vaginal isonicotinic acid hydrazide (INH) administration 12 hours before hysterosalpingography in primarily infertile patients". EKB Journal Management System, 27, 2, 2023, 54-64. doi: 10.21608/egyfs.2023.297300
shady, N., Taha, A., Ahmed, H., Sallam, H. (2023). 'A randomized double-blinded clinical trial to explore the clinical outcome of self-administered vaginal isonicotinic acid hydrazide (INH) administration 12 hours before hysterosalpingography in primarily infertile patients', EKB Journal Management System, 27(2), pp. 54-64. doi: 10.21608/egyfs.2023.297300
shady, N., Taha, A., Ahmed, H., Sallam, H. A randomized double-blinded clinical trial to explore the clinical outcome of self-administered vaginal isonicotinic acid hydrazide (INH) administration 12 hours before hysterosalpingography in primarily infertile patients. EKB Journal Management System, 2023; 27(2): 54-64. doi: 10.21608/egyfs.2023.297300